Metastatic Colorectal Cancers Unknown Status Phase 2 Trials for Cetuximab (DB00002)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00784667Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and ErlotinibTreatment
NCT00852228Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of ChemotherapyTreatment
NCT00931840A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal CarcinomaTreatment